The relationship between percent time less than 70 mg/dl and percent time less than 54 mg/dl measured by continuous glucose monitoring
Beck RW, Raghinaru D, Calhoun P, Bergenstal MR
Diabetes Technol Ther. Pub. online 28 Dec 2022.
Leggi
Breaking news
Lipoprotein(a) in youth and prediction of major cardiovascular outcomes in adulthood
Raitakari O, Kartiosuo N, Pahkala K, et al.
Circulation. 2023;147(1):23-31.
Leggi
Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial
Yamaguchi S, Shimabukuro M, Tanaka A, et al.
Diabetes Obes Metab. 2023;25(2):354-64.
Leggi
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes
Moody AJ, Molina-Wilkins M, Clarke GD, et al.
Diabetes Obes Metab. 2023;25(2):426-34.
Leggi
Standards of Medical Care in Diabetes – 2023
American Diabetes Association
Diabetes Care. 2023;46(Supplement_1):S1-S284.
Leggi
Once-weekly semaglutide in adolescents with obesity
Weghuber D, Barrett T, Barrientos-Pérez M, et al.
N Engl J Med. 2022;387:2245-2257.
Leggi
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial
Lee YJ, Cho JY, You SC, et al.
European Heart Journal. ehac709.
Leggi
Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century
Lazzarini PA, Cramb SM, Golledge J, et al.
Diabetologia. Pub. online 13 Dec 2022.
Leggi
MiniMed 780G™ in 2–6-year-old children: safety and clinical outcomes after the first 12 weeks
Pulkkinen MA, Varimo T, Hakonen ET, et al.
Diabetes Technol Ther. Pub. online 13 Dec 2022.
Leggi
GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes
Marx N, Husain M, Lehrke M, et al.
Circulation. 2022;146:1882-1894.
Leggi